Ingevity is a manufacturer of specialty chemicals and activated carbon materials. The company reports in two business segments: Performance Materials, which manufactures and sells hardwood-based, chemically activated carbon products, produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles and boats; and Performance Chemicals, which is comprised of four application areas (pavement technologies, oilfield technologies, industrial specialties, and engineered polymers), develops, manufactures, and sells a range of specialty chemicals primarily derived from co-products of the kraft pulping process and caprolactone.
  • TickerNGVT
  • ISINUS45688C1071
  • ExchangeNew York Stock Exchange
  • SectorChemicals
  • CountryUnited States

Thanks to a better fundamental star rating, INGEVITY CORPORATION sees an upgrade to Neutral

The independent financial analyst theScreener just awarded an improved star rating to INGEVITY CORPORATION (US), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 3 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date May 1, 2020, the closing price was USD 47.88 and its expected value was estimated at USD 43.04.

Ingevity Corporation: Improved debt leverage after strong 2019 earnings

Our credit view of Ingevity Corporation after 2019 results

Ingevity Corp: 2 directors bought

Two Directors at Ingevity Corp bought 5,650 shares at between 34.750USD and 39.370USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules...

Moody's changed Ingevity's outlook to stable from negative and affirmed its Ba2 CFR

Rating Action: Moody's changed Ingevity's outlook to stable from negative and affirmed its Ba2 CFR. Global Credit Research- 11 Mar 2020. New York, March 11, 2020-- Moody's Investors Service has changed Ingevity Corporation's outlook to stable from negative.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Emerging markets are attempting a reversal. We believe this would be a positive sign for the U.S markets and the Materials Sector. • Starbucks and a number of restaurant stocks are developing positively. • Chemical stocks are near breakouts or attempting to stage price and RS reversals.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Biotechs continue to be leadership. We have highlighted a number of names in today's Vital Signs. • Many retail related names have pulled back to logical support. See today's Vital Signs for many of these stocks. • A number of Auto Component Suppliers and Homebuilders appear to be stabilizing. We did not highlight them in this report, but will continue to watch for reversals

Ingevity Corp: 2 directors bought

Two Directors at Ingevity Corp bought 5,650 shares at between 34.750USD and 39.370USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules...

Jonathan Moreland

InsiderInsights Daily Ratings Report: February 6, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Ingevity Corporation: Improved debt leverage after strong 2019 earnings

Our credit view of Ingevity Corporation after 2019 results

Moody's changed Ingevity's outlook to stable from negative and affirmed its Ba2 CFR

Rating Action: Moody's changed Ingevity's outlook to stable from negative and affirmed its Ba2 CFR. Global Credit Research- 11 Mar 2020. New York, March 11, 2020-- Moody's Investors Service has changed Ingevity Corporation's outlook to stable from negative.

Ingevity Corporation: Update to credit analysis

Our credit view of Ingevity Corporation after the caprolactone acquisition and incremental issuance of secured debt

Moody's announces completion of a periodic review of ratings of Ingevity Corporation

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Ingevity Corporation. Global Credit Research- 08 Nov 2019. New York, November 08, 2019-- Moody's Investors Service has completed a periodic review of the ratings of Ingevity Corporation and other ratings that are associated with the same analytical unit.

Thanks to a better fundamental star rating, INGEVITY CORPORATION sees an upgrade to Neutral

The independent financial analyst theScreener just awarded an improved star rating to INGEVITY CORPORATION (US), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 3 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date May 1, 2020, the closing price was USD 47.88 and its expected value was estimated at USD 43.04.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch